Substance Use Disorders: Brains, Behavior & Diagnosis | August 6, 2020
Date of Presentation: August 6, 2020
Type: Past Presentation
Audience: Clinical
Program: Substance Use Disorder ECHO Program
Keywords: #benzodiazepine #kratom
Dr. Jonathan Robbins, an Assistant Professor of Medicine at Oregon Health & Science University, shares information to help interpret a “negative” benzodiazepine urine drug screen, discusses how to the determine next steps for further confirmatory testing and how to recognize the emergence of novel psychoactive substances, as well as the challenges of monitoring and reporting in a rapidly changing drug-use landscape.
Recording:
Presenter Bio:
Dr. Jonathan Robbins
Jonathan Robbins, MD, MS, is an internal medicine doctor at Oregon Health & Science University. He has a special interest in the treatment of people with opioid use disorders, including those struggling with homelessness. He also instructs primary care doctors throughout Oregon on how to improve their ability to diagnose, treat and manage patients with persistent pain and opioid-use disorder.
Resource Provided:
- KRATOM: It Must Be Safe Because It Comes From a Plant, Man
- Use of Buprenorphine-Naloxone in Pregnancy
- Buprenorphine for Opioid Use Disorders During Pregnancy: A Review of Comparative Clinical Effectiveness, Safety, Cost-Effectiveness, and Guidelines
Date added: August 6, 2020